(MIR) Miraculum - Ratings and Ratios
Exchange: WAR • Country: Poland • Currency: PLN • Type: Common Stock • ISIN: PLKLSTN00017
MIR: Skincare, Fragrances, Haircare, Makeup, Personal Care
Miraculum S.A., established in 1924 and headquartered in Warsaw, Poland, is a longstanding cosmetics company specializing in the development, production, and distribution of personal care products. The companys extensive portfolio includes face and body care, perfumes, depilation products, makeup, shaving items, deodorants, and hair care solutions. Miraculum operates under a diverse range of brands, including Pani Walewska, Miraculum, Gracja, Tanita, Paloma, Joko, Chopin, Lider, Wars, and Byc Moze, catering to both men and women in Poland and international markets. With nearly a century of experience, the company has built a strong market presence in the personal care sector.
As a key player in the cosmetics industry, Miraculum S.A. focuses on delivering a wide array of products that meet evolving consumer preferences. Its brand portfolio reflects a mix of heritage and innovation, with products tailored to different demographics and preferences. The companys strategic approach includes maintaining a strong distribution network and leveraging its long-standing reputation for quality and affordability.
From a market perspective, Miraculum S.A. operates in a competitive landscape, with its performance influenced by consumer trends, pricing strategies, and regulatory environments. The companys ability to adapt to changing market dynamics, coupled with its established brand equity, positions it as a significant contender in the personal care products sector.
Objective: Miraculum S.A. is a Poland-based cosmetics company with a diverse portfolio of personal care products, operating under multiple brands to serve men and women domestically and internationally. 3-Month Forecast: Based on the providedAdditional Sources for MIR Stock
MIR Stock Overview
Market Cap in USD | 11m |
Sector | Consumer Defensive |
Industry | Household & Personal Products |
GiC Sub-Industry | Personal Care Products |
IPO / Inception |
MIR Stock Ratings
Growth Rating | -55.5 |
Fundamental | 10.8 |
Dividend Rating | 0.0 |
Rel. Strength | -43.1 |
Analysts | - |
Fair Price Momentum | 0.65 PLN |
Fair Price DCF | - |
MIR Dividends
No Dividends PaidMIR Growth Ratios
Growth Correlation 3m | -76.7% |
Growth Correlation 12m | -90.2% |
Growth Correlation 5y | -44.4% |
CAGR 5y | -9.97% |
CAGR/Max DD 5y | -0.16 |
Sharpe Ratio 12m | -0.12 |
Alpha | -42.05 |
Beta | 0.426 |
Volatility | 44.24% |
Current Volume | 0k |
Average Volume 20d | 8.9k |
As of April 19, 2025, the stock is trading at PLN 0.78 with a total of 10 shares traded.
Over the past week, the price has changed by -4.16%, over one month by -5.31%, over three months by -6.44% and over the past year by -35.21%.
Neither. Based on ValueRay Fundamental Analyses, Miraculum is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 10.80 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MIR as of April 2025 is 0.65. This means that MIR is currently overvalued and has a potential downside of -16.67%.
Miraculum has no consensus analysts rating.
According to ValueRays Forecast Model, MIR Miraculum will be worth about 0.7 in April 2026. The stock is currently trading at 0.78. This means that the stock has a potential downside of -10.26%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 0.9 | 9% |
Analysts Target Price | - | - |
ValueRay Target Price | 0.7 | -10.3% |